About The Study: In Chinese adults with obesity or overweight, once-weekly injection with tirzepatide 10 mg or 15 mg resulted in statistically significant and clinically meaningful weight reduction with an acceptable safety profile.
About The Study: In Chinese adults with obesity or overweight, once-weekly injection with tirzepatide 10 mg or 15 mg resulted in statistically significant and clinically meaningful weight reduction with an acceptable safety profile.
Corresponding Author: To contact the corresponding author, Xiaoying Li, M.D., email li.xiaoying@zshospital.sh.cn.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jama.2024.9217)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
Journal
JAMA
